DelftA, DramowskiA, SifumbaZ. Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students. Clin Infect Dis2016; 62: S275-80.
2.
SardanaR, SardanaNK, SharmaA. Tuberculosis of the axial skeleton mimicking malignancy. R Coll Physicians Edinb2020; 50: 168–70.
3.
MassiMS, BiatkoKT, HandayaniI. Evaluation of rapid GeneXpert MTB/RIF method using DNA tissue specimens of vertebral bones in patients with suspected spondylitis TB. J Orthop2017; 14: 189–91.
4.
NiemziA, BoyleDS. Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries. Expert Rev Mol Diagn2012; 12: 687–701.
5.
PandeyP, PantND, RijalKR. Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis. PLoS One2017; 12: e0169798.
6.
ThomsenVO, Kok-JensenA, BuserM. Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied?J Clin Microbiol1999; 37: 3601–7.
7.
TrinkerM, HóflerG, SillH. False-positive diagnosis of tuberculosis with PCR. Lancet1996; 348:1388.
